Metabonomic study on the biochemical response of spontaneously hypertensive rats to chronic taurine supplementation using 1H NMR spectroscopic urinalysis

Journal of Pharmaceutical and Biomedical Analysis

Volumn 85, Issue , 2013, Pages 155-161

  Akira, Kazuki ^a   Hichiya, Hiroyuki ^a   Morita, Mayu ^a   Shimizu, Akane ^a   Mitome, Hidemichi ^a  

^a MATSUYAMA UNIVERSITY   (Japan)

Author keywords

Hypertension; Metabonomics; NMR; Rat; Taurine; Urine

Indexed keywords

DRINKING WATER; TAURINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CITRIC ACID CYCLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; MALE; METABOLIC ACIDOSIS; METABOLITE; METABOLOMICS; MICROBIAL METABOLISM; MOLECULAR WEIGHT; NONHUMAN; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; TREATMENT DURATION; URINALYSIS; URINE VOLUME;

HYPERTENSION; METABONOMICS; NMR; RAT; TAURINE; URINE;

ACIDOSIS; ANIMALS; BLOOD PRESSURE; CITRIC ACID CYCLE; CRESOLS; DIETARY SUPPLEMENTS; GLYCINE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOMICS; RATS; RATS, INBRED SHR; SULFURIC ACID ESTERS; TAURINE; URINALYSIS;

EID: 84882681382     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2013.07.018     Document Type: Article

References (34)

1. Abebe W., Mozaffari M.S. Role of taurine in the vasculature: an overview of experimental and human studies. American Journal of Cardiovascular Disease 2011, 1:293-311.
2. Shao A., Hathcock J.N. Risk assessment for the amino acids taurine, l-glutamine and l-arginine. Regulatory Toxicology and Pharmacology 2008, 50:376-399.
3. Xu Y.-J., Arneja A.S., Tappia P.S., Dhalla N.S. The potential health benefits of taurine in cardiovascular disease. Experimental & Clinical Cardiology 2008, 13:57-65.
4. Militante J.D., Lombardini J.B. Treatment of hypertension with oral taurine: experimental and clinical studies. Amino Acids 2002, 23:381-393.
5. Nara Y., Yamori Y., Lovenberg W. Effect of dietary taurine on blood pressure in spontaneously hypertensive rats. Biochemical Pharmacology 1978, 27:2689-2692.
6. Robertson D.G., Watkins P.B., Reily M.D. Metabolomics in toxicology: preclinical and clinical applications. Toxicological Sciences 2011, 120(S1):S146-S170.
7. Zhang S., Gowda G.A.N., Ye T., Raftery D. Advances in NMR-based biofluid analysis and metabolite profiling. Analyst 2010, 135:1490-1498.
8. An D., Zhang Q., Wu S., Wei J., Yang J., Dong F., Yan X. Changes of metabolic profiles in urine after oral administration of quercetin in rats. Food and Chemical Toxicology 2010, 48:1521-1527.
9. Liu G., Wang Y., Wang Z., Cai J., Lv X., Zhou A. Metabolomic studies on the biochemical profile of urine from rats with acute cysteamine supplementation. Metabolomics 2011, 7:536-541.
10. 1H NMR spectroscopy. Journal of Pharmaceutical and Biomedical Analysis 2010, 52:136-141.
11. 1H nuclear magnetic resonance-based metabonomics. Hypertension Research 2005, 28:425-430.
12. 1H NMR-based metabonomic analysis of urine from young spontaneously hypertensive rats. Journal of Pharmaceutical and Biomedical Analysis 2008, 46:550-556.
13. 1H NMR spectroscopic urinalysis. Hypertension Research 2012, 35:404-412.
14. Akira K., Hichiya H., Shuden M., Morita M., Mitome H. Sample preparation method to minimize chemical shift variability for NMR-based urinary metabonomics of genetically hypertensive rats. Journal of Pharmaceutical and Biomedical Analysis 2012, 66:339-344.
15. 13C NMR spectroscopy of human blood plasma. Analytical Chemistry 1995, 67:793-811.
16. 1H NMR spectroscopy of urine and pattern recognition. Analytical Biochemistry 2001, 295:194-202.
17. Lindon J.C., Nicholson J.K. Biofluids studied by NMR. Encyclopedia of Spectroscopy and Spectrometry 2000, vol. 1:98-116. Academic Press, London.
18. Bohus E., Coen M., Keun H.C., Ebbels T.M.D., Beckonert O., Lindon J.C., Holmes E., Noszal B., Nicholson J.K. Temporal metabonomic modeling of l-arginine-induced exocrine pancreatitis. Journal of Proteome Research 2008, 7:4435-4445.
19. 35S]taurine in man. Journal of Nutrition 1975, 105:1206-1214.
20. Federici G., Dupre S., Rosei M.A., Granata F., Orlando M. The metabolism of taurine in the living rat. Physiological Chemistry and Physics 1974, 6:411-416.
21. 1H NMR-based metabonomics of genetically hypertensive rats. Journal of Pharmaceutical and Biomedical Analysis 2010, 51:1091-1096.
22. Mortishire-Smith R.J., Skiles G.L., Lawrence J.W., Spence S., Nicholls A.W., Johnson B.A., Nicholson J.K. Use of metabonomics to identify impaired fatty acid metabolism as the mechanism of a drug-induced toxicity. Chemical Research in Toxicology 2004, 17:165-173.
23. Hamm L.L. Renal handling of citrate. Kidney International 1990, 38:728-735.
24. Melnick J.Z., Srere P.A., Elshourbagy N.A., Moe O.W., Preisig P.A., Alpern R.J. Adenosine triphosphate citrate lyase mediates hypocitraturia in rats. Journal of Clinical Investigation 1996, 98:2381-2387.
25. Sharma A.M., Distler A. Acid-base abnormalities in hypertension. American Journal of the Medical Sciences 1994, 307(Suppl. 1):S112-S115.
26. Sharma A.M., Kribben A., Schattenfroh S., Cetto C., Distler A. Salt sensitivity in humans is associated with abnormal acid-base regulation. Hypertension 1990, 16:407-413.
27. Lucas P.A., Lacour B., McCarron D.A., Drueke T. Disturbance of acid-base balance in the young spontaneously hypertensive rat. Clinical Science 1987, 73:211-215.
28. Debska-Slizien A., Ho P., Drangova R., Baines A.D. Endogenous dopamine regulates phosphate reabsorption but not NaK-ATPase in spontaneously hypertensive rat kidneys. Journal of the American Society of Nephrology 1994, 5:1125-1132.
29. Hansen S.H., Andersen M.L., Cornett C., Gradinaru R., Grunnet N. A role for taurine in mitochondrial function. Journal of Biomedical Science 2010, 17(Suppl. 1):S23-S30.
30. Clayton T.A., Baker D., Lindon J.C., Everett J.R., Nicholson J.K. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proceedings of the National Academy of Sciences of the United States of America 2009, 106:14728-14733.
31. Lesaffer G., de Smet R., Belpaire F.M., van Vlem B., van Hulle M., Cornelis R., Lameire N., Vanholder R. Urinary excretion of the uraemic toxin p-cresol in the rat: contribution of glucuronidation to its metabolization. Nephrology Dialysis Transplantation 2003, 18:1299-1306.
32. Klaassen C.D., Boles J.W. The importance of 3'-phosphoadenosine 5'-phosphosulfate (PAPS) in the regulation of sulfation. FASEB Journal 1997, 11:404-418.
33. Hepner G.W., Sturman J.A., Hofmann A.F., Thomas P.J. Metabolism of steroid and amino acid moieties of conjugated bile acids in man. III. Cholyltaurine (taurocholic acid). Journal of Clinical Investigation 1973, 52:433-440.
34. Holmes E., Li J.V., Athanasiou T., Ashrafian H., Nicholson J.K. Understanding the role of gut microbiome-host metabolic signal disruption in health and disease. Trends in Microbiology 2011, 19:349-359.